Thursday 5 March 2020
The UK’s National Nuclear Laboratory has further strengthened its links with Canadian Nuclear Laboratories (CNL) by developing an Action Plan under an existing Memorandum of Understanding (MoU). The Action Plan is specifically designed to boost collaboration across the areas of clean energy, medical isotopes, waste management and decommissioning. The agreement will address shared challenges between the UK and Canada in relation to climate change, public health and environmental stewardship.
Under the terms of the agreement, NNL and CNL will work in partnership to explore and pursue joint research projects and studies, information exchange workshops and other resource and knowledge-sharing opportunities. Both parties have identified research related to advance nuclear reactor fuel, targeted alpha therapy and medical isotope production and environmental remediation practices and technologies as key areas that both Laboratory’s intend to pursue in partnership.
NNL Chief Executive Officer, Paul Howarth said:
“Collaborative working is an essential part of how NNL operates and succeeds. The MoU between CNL and NNL has been an excellent way of opening links between our two organisations. However, this Action Plan takes us a big step further forward and means that we will now begin to see outputs from our collaboration which will benefit both the UK and Canada.”
CNL President and Chief Executive Officer, Mark Lesinski commented:
“Canada and the United Kingdom have a long history of working together to tackle some of the world’s most pressing challenges through nuclear science and technology but we still have a lot to learn from one another, and I am thrilled that this tradition of collaboration will continue through this agreement.
“The Action Plan will allow CNL and NNL to share expertise, facilities, equipment and other resources to achieve key public policy goals in Canada and the UK, including the development of new technologies to better protect the environment, fight climate change and treat many difficult forms of cancer.”
For more information about CNL, please visit https://www.cnl.ca